Skip to main content
GraniteShares YieldBOOST CRCL ETF logo

GraniteShares YieldBOOST CRCL ETF Share Price

$12.83

-4.48 (25.88%)

    Live GraniteShares YieldBOOST CRCL ETF Share Price Chart

    O H L

    GraniteShares YieldBOOST CRCL ETF Performance Overview

    Days Range
    $17.31Low
    $17.31High

    Markets Today

    Previous Close$16.95
    Open$17.31
    Volume7,996
    Day's Range$17.31 - $17.31
    52W RangeNA

    Historical Performance

    1M ReturnsNA
    3M ReturnsNA
    6M ReturnsNA
    1Y ReturnsNA
    5Y ReturnsNA
    10Y ReturnsNA

    GraniteShares YieldBOOST CRCL ETF Fundamentals

    Avg. PE RatioN/A
    Avg. PB RatioN/A
    Avg. PE RatioN/A
    Avg. PB RatioN/A

    GraniteShares YieldBOOST CRCL ETF Peer Comparison

    CompanyLTP(NAV)ChangeChange %Asset(Cr.)Exp Ratio
    AAA
    24.860.010.04%NANA
    AA
    AAAA
    14.670.080.26%NANA
    AA
    AAAC
    17.03-0.04-0.22%NANA
    AA
    AAAD
    23.60NANANANA
    AAAP
    12.72-0.01-0.02%NANA
    NOVZ
    22.910.260.55%NANA
    RI
    RISE
    17.420.180.96%NANA
    RT
    RTYY
    6.750.151.82%NANA
    RULE
    14.370.180.61%NANA
    TPZ
    16.000.844.01%NANA

    About GraniteShares YieldBOOST CRCL ETF

    Artivion, Inc. (Artivion), formerly CryoLife, Inc., is a medical device company. The Company is focused on developing various solutions that address cardiac and vascular surgeons' challenges in treating patients with aortic diseases. The Company's four groups of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion's cryopreserved cardiac and vascular allograft tissues help in restoring surgeries for adults and pediatric patients. It offers surgical sealant through BioGlue product. Its surgical aortic valve replacement solutions include On-X Aortic Heart Valves and CryoValve SG Pulmonary Valve Allograft for the Ross procedure. The Company's mitral valve solutions include Chord-X for mitral valve repair and On-X Mitral Heart Valve. Artivion's Cardiac and Vascular Ancillary solutions provide complementary support for the patient's cardiac and vascular surgical procedures.

    Frequently Asked Questions

    The GraniteShares YieldBOOST CRCL ETF (CRY) price as of September 16, 2026 is $12.83. If you are investing from India, you can check the value in INR before investing.
    Yes, Indian investors can buy GraniteShares YieldBOOST CRCL ETF (CRY) in the US market by opening an International Trading Account with Angel One.
    Indian investors can buy GraniteShares YieldBOOST CRCL ETF (CRY) through the following modes:
    1. Direct investment: One can invest through opening an International Trading Account with Angel One. Once account is opened, you can add funds in U.S. dollars to buy GraniteShares YieldBOOST CRCL ETF (CRY).
    2. Indirect investment: One can invest indirectly in GraniteShares YieldBOOST CRCL ETF (CRY) through mutual funds and Exchange Traded Funds (ETFs) that offer exposure to global stocks.
    Yes, you can buy fractional shares of GraniteShares YieldBOOST CRCL ETF (CRY) on Angel One.

    Investing in US ETFs Simplified

    One fund, hundreds of top US companies

    +91
    Top US ETFs

    VIEW ALL

    Open Free Demat Account!

    Join our 3.8 Cr+ happy customers
    +91